Dr. Bonham joins as chief pathologist and executive medical director.

The patch provides real time monitoring for remote patients.

The assay, developed by Abbott Laboratories, is used to detect the hepatitis B surface antigen.

Poulidis discusses how AI is being used by the pharma industry for marketing and sales.

The partnership will focus on developing Lunit's SCOPE, an AI biomarker platform.

The updates will be implemented on the Eureka Clinical AI platform.

CGI, Helsinki University Hospital, and Planmeca announced the partnership.

The platform will accelerate cell therapy discovery, development, and manufacturing.

McDonough speaks with MDT about ChromaCode’s HD PCR technology and the company’s recent expansion to India and the Middle East.

The software, named Health Verity FLOW, will integrate data from real-world examples, clinical trials, and other registries for pharmaceutical manufacturers.

If certified, Tasso would be able to offer its services to additional markets.

Chan discusses the AI imaging technology recently used alongside a steerable needle during a successful lung biopsy.

The two companies will work together to create digital twins to fight the cancer.

The U.S. Department of Defense awarded the contract with the goal of developing and providing a device that can be used in the field.

While Q2 results are still to come, investment dollars lagging far behind 2021.

The platform, called Target Discovery, allows for more efficient discovery and information retrieval.

Wood discusses how AI is being used to improve the process of finding patients for clinical trials.

The move will increase the firm's presence in Germany, Austrian, and Switzerland.

The platform connects cancer patients with potential treatment options.

Taking the physician's workflow into account can pave the way for greater acceptance of digital therapeutics.

The software is based on medical imaging technology.

This project has the ability to extend digital clinical measures to larger audiences.

The company is teaming up with Singapore's Institute for Clinical Sciences on the initiative.

Peripheral neurostimulator for tibial nerve stimulation for incontinence treatment is delivered through an implantable device.

Snyder discusses how digital tools are changing the ways that patients interact with doctors.

The healthcare technology company is working with Saitama Medical University Hospital in Japan on the trial.

HDPCR technology assists laboratories cataloging biomarkers.

The wearable tech company is partnering with the veteran and active military personal focused company.

Marc Eigner, executive chairman of the board at Datacubed, details the ways his company is improving clinical trials.

Tedman speaks about how digital platforms are improving the ways that companies find patients for clinical trials.